Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]
Simon Fishel, Deborah Baker, Janine Elson and 7 more
EBioMedicine · 2016
doi:10.1016/j.ebiom.2016.08.031 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The authors wish to point out that there is an error in the Abstract (Findings paragraph) of this article, whereby the 47.7% for male ANXA5 M2 only should have been 58.3%, as is in Table 5 and in Results section of the article.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.